Reading LMND? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track LMND free→Reading LMND? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track LMND free→
NYSEFinancialsInsurance - Property & CasualtySnapshot 2026-06-16
Recent financial performance sits well below its industry cohort — worth keeping an eye on, though it has not freshly broken.
Recent financial performance is weak, and the company was unprofitable over the past year, so its earnings quality can't be assessed. Management's recent track record has been steady, but risk is high, and the sector backdrop is a headwind. Compared with sector peers, LMND is below typical. Peer multiples imply a price about 346% below where it trades (it looks expensive on this basis); the read is rich. This assessment is provisional.
Daily closes. Earnings/event dots are placed inline.
A consensus fair price across 2 valuation methods, at three horizons. Current price $60.78. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
No-growth: today's peer multiple on trailing earnings. The headline read.
Embeds projected growth. Leans optimistic by design. Upside context.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $61, LMND's earnings are too small for P/E to mean much; on sales it trades at 6× p/s (4.1× the 1× p/s peer median). At a normal multiple the price implies ~329% near-term growth vs our ~54% forecast. That gap is an optionality premium a financial-multiple model can't price — our $14 fair value covers only the as-is business, low confidence. Analysts: $44–$80. Not investment advice.
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
The market is pricing in roughly 329% near-term growth, well above our forecast of about 54%. This describes what's priced in, not a forecast of the move.
TTM earnings are negative, so the read leans on sales- and cash-flow-based methods rather than P/E. This is a data condition, not a forward call.
Flags: expensive valuation, a turbulent sector regime (Heating).
For similar setups historically (n=2,301): about 43% saw a 20%+ drawdown, and roughly 77% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
Each factor is a parallel diagnostic with a clear read of what it shows and how names like it have historically fared. Never aggregated into a single score.
Operating income rose in 2 of the last 3 quarter-over-quarter moves. Historically, Financials names rated weak grew net income 56% of the time over the next year (vs 59% for the rest of the cohort, n=3730).
Over the trailing year it converted -0.22x of net income into operating cash flow.
Most sensitive to the broad stock market.
Not enough signal to read sensitivity to the US dollar, long-term interest rates, Fed net liquidity, real (inflation-adjusted) rates.
The next print and the backdrop around it (sector regime and the AI cycle). Context for the path, not a forecast of returns.
EPS estimate $-0.56 → $-0.57 (-1.0% / 30d). 3 raised, 3 cut, 11 covering analysts.
0 upgrades, 0 downgrades / 30d, 1 maintained. 36% of analysts rate Buy.
1 PT revisions / 30d. Avg target 31.3% above current price.
How management runs the business: capital, margins, balance sheet, and how reliably they guide and deliver.
A guidance track record builds as the company issues and delivers on guidance.
What a normal day, a bad day, and the worst of the last year would mean for a $10,000 position.
On a typical day, $10k can swing ±$247.
How much price usually moves either way.
On a bad day, this stock has moved -$766.
A rough but not unusual down day (about the 95th percentile).
In the worst 12 months, $10k could have lost $4,770.
Deepest peak-to-trough drop in the last year.
Past results, not a forecast. Not investment advice.
The most important moves since the prior daily snapshot.
No material changes since the prior snapshot.
as of 2026-06-16
Specific, dated things to watch for, each with what would confirm it and what would prove it wrong.
Why it matters: A drop below 15% would signal a slowdown in revenue growth for Lemonade. This could indicate a worsening trend in the financial sector.
Confirms:Q2 revenue growth reported below 15%.
Disproves:Q2 revenue growth remains at or above 15%.
Recent news graded against this company's own objectives — whether it reinforces or challenges the thesis, and how confirmed it is.
No graded news catalysts for LMND yet.
Conditional scenarios: if X happens, the view would shift in this direction. These are not predictions.
Recent SEC 8-K filings ranked by likely impact, confidence, and recency.
of this Report (including Exhibit 99.1 attached hereto) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly provided by specific reference in such a filing.
Whether the overall read has been drifting up or down lately, and how it's changed since last week.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Long-thesis check; widest uncertainty.
TTM earnings are negative. P/E-based methods drop out and the estimate leans on sales- and cash-flow-based methods. A data condition, not a forward call.
$44.00 – $80.00 (median $70.00) · 5 analysts · as of 2026-05-21
Looks more expensive than peers.
Self-history needs ~20 months of data.
Trailing four: 2025-Q1, 2025-Q2, 2025-Q3, 2026-Q1
A side-by-side read on sector standing, valuation, and risk versus Property & Casualty Insurance.
| Stock | Sector standing | Valuation | Risk |
|---|---|---|---|
LMND Lemonade, Inc. | Below typical Show detailsSector percentile: 19 of 100 | expensive | high |
CB Chubb Limited | Typical Show detailsSector percentile: 70 of 100 | full | moderate |
PGR Progressive Corporation | Above typical Show detailsSector percentile: 74 of 100 | fair | moderate |
TRV Travelers Companies (The) | Above typical Show detailsSector percentile: 88 of 100 | fair | low |
ALL Allstate | Above typical Show detailsSector percentile: 89 of 100 | inexpensive | moderate |
4 material management or governance events in the past 24 months, led by M&A activity. Historically, Financials names rated stable grew net income 56% of the time over the next year (vs 56% for the rest of the cohort, n=3736).
Not investment advice. As of 2026-06-16.
via XLF
Tailwind = sector leading the S&P 500; headwind = trailing. Both can be constructive. Historically, headwind regimes have averaged stronger forward returns than tailwind.
Context label only: describes the market state (e.g. real bear vs narrative panic, healthy uptrend vs late-stage froth). It is not a per-ticker buy/sell signal and does not predict factor performance.
Not investment advice. As of 2026-06-16.
Priorities management has stated in recent disclosures, with status and evidence drawn from earnings calls, filings, and press releases.
Management has raised the revenue guidance for fiscal year 2026, reflecting improved expectations.
Management aims to improve the Adjusted EBITDA loss by more than 50% compared to 2025.
Management is focused on achieving positive cash flow from operations.
of this Report (including Exhibit 99.1 attached hereto) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly provided by specific reference in such a filing.
of this Report (including Exhibit 99.1 attached hereto) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly provided by specific reference in such a filing.
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On October 15, 2025, the Board, upon the recommendation of its Nominating and Corporate Governance Committee, appointed Mr. Prashant Ratanchandani to the Board effective October 15, 2025. Mr. Ratanchandani will serve as a Class II director for a term expiring at the Company’s annual meeting of stockholders to be held in 2028, until his successor is…
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On October 6, 2025, the Board, upon the recommendation of its Nominating and Corporate Governance Committee, appointed Mr. Geoff Seeley to the Board effective October 6, 2025. Mr. Seeley will serve as a Class I director for a term expiring at the Company’s annual meeting of stockholders to be held in 2027, until his successor is duly elected and qu…